The shifting model in clinical diagnostics: how next-generation sequencing and families are altering the way rare diseases are discovered, studied, and treated-Reference-Cited by-同舟云学术

The shifting model in clinical diagnostics: how next-generation sequencing and families are altering the way rare diseases are discovered, studied, and treated

Published:2014-10 Issue:10 Volume:16 Page:736-737
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Might Matthew,Wilsey Matt

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

http://www.nature.com/articles/gim201423.pdf

Reference3 articles.

1. Enns GM, Shashi V, Bainbridge M, et al. Mutations in NGLY1 cause an inherited disorder of the endoplasmic reticulum–associated degradation pathway. Genet Med 2014;this issue (http://www.nature.com/doifinder/10.1038/gim.2014.22).

2. Might M. Hunting down my son’s killer. http://matt.might.net/articles/my-sons-killer/ Accessed December 25th, 2013.

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional prediction of the potential NGLY1 mutations associated with rare disease CDG;Heliyon;2024-04

2. The book is just being written: The enduring journey of parents of children with emerging‐ ultrarare disorders;Journal of Genetic Counseling;2024-04

3. A Natural Compound Containing a Disaccharide Structure of Glucose and Rhamnose Identified as Potential N-Glycanase 1 (NGLY1) Inhibitors;Molecules;2023-11-24

4. Integrating non-mammalian model organisms in the diagnosis of rare genetic diseases in humans;Nature Reviews Genetics;2023-07-25

5. “Sync fast and solve things” – best-practices for responsible digital health;2023-06-28